-
Mar 11, 2022, 14:08 PM
by
Examen, leaders in male fertility research and diagnostics, is delighted to announce that semen analysis is now available at its Belfast facility. This comes in response to unprecedented demand for fertility services as couples continue to face delays in accessing appointments owing to the backlog caused by the pandemic.
Full story
-
Mar 11, 2022, 14:08 PM
by
Summit to be co-chaired by Cotiviti Executive Vice President RaeAnn Grossman
Full story
-
Mar 11, 2022, 14:08 PM
by
UK Regulator Cites CluePoints’ Solutions in Updated Guidance
MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.
Full story
-
Mar 11, 2022, 14:08 PM
by
Full story
-
Mar 11, 2022, 14:08 PM
by
Full story
-
Mar 11, 2022, 14:08 PM
by
Oxford Medical Products has raised £2.5M in equity investment to conduct first human trials of Sirona, its innovative non-surgical weight-loss solution. Sirona is a hydrogel-based technology in a tablet format that, once swallowed, expands in the stomach, stops feelings of hunger and suppresses appetite.
Full story
-
Mar 11, 2022, 14:08 PM
by
Full story
-
Mar 11, 2022, 14:08 PM
by
Abdul Butt joins Watson-Marlow Fluid Technology Group as Operations and Supply Director to drive the company’s supply excellence and enable continued growth. Abdul joins the company with extensive experience in Manufacturing and Operational Excellence, including 20 years at GKN PLC and then Melrose Industries as CEO of one of their divisions, followed by MPP where he was Chief Operating Officer in his most recent role.
Full story
-
Mar 11, 2022, 14:08 PM
by
NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
Full story
-
Mar 11, 2022, 14:08 PM
by
MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance.
Full story
-
Mar 11, 2022, 14:08 PM
by
Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
Full story
-
Mar 11, 2022, 14:08 PM
by
Full story
-
Mar 11, 2022, 14:08 PM
by
Full story
-
Mar 10, 2022, 01:00 AM
by
User Not Found
Bio-IT World | A new method to screen drugs for treating Alzheimer’s disease could significantly improve the odds of therapeutic success by analyzing causal mechanisms in human neurons, according to Shankar Subramaniam, professor of bioengineering at the University of California (UC) San Diego. The plan now is to extend the work to organoids with microglia cells and vasculature, creating “realistic human brain avatars” for better understanding disease endotypes and their response to treatment.
Full story
-
Mar 8, 2022, 01:00 AM
by
User Not Found
Bio-IT World | As Executive Director of Enterprise Data Engineering and Analytics at CVS Health, Saira Kazmi uses her background in computer science and engineering in both academic and industry positions to inform her new role. She learned about the importance of iterative testing under the tightest timelines from the industry and got a first-hand view of the engineering rigor required to enable bioinformatics from her academic career. Now she is focused on creating data assets and managing the data life cycle at the enterprise level for a major healthcare player.
Full story
-
Mar 7, 2022, 01:00 AM
by
User Not Found
Bio-IT World | An organoid model is being used to flush out what’s behind production of a rare subset of cells in the human intestine and the hormones they manufacture, including four that seem to have the most effect on decreasing appetite.
Full story
-
Mar 3, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Our technical capabilities are becoming increasingly granular, and proteomics is no exception. At the recent Molecular & Precision Med TRI-CON, Christopher Rose reported on how his group within the Microchemistry, Proteomics & Lipidomics department at Genentech where he currently leads the Discovery Proteomics group is working to build a single-cell proteomics platform.
Full story
-
Mar 2, 2022, 15:01 PM
by
User Not Found
Bio-IT World | Structural variant detection in FFPE samples, new federated network for genomic variant surveillance, Element Biosciences’ new acquisitions and collaborations, RNA profiling to predict preterm birth, release of multi-modal mental health dataset, AI in genetic variant analysis for cancer and beta-propeller protein-associated neurodegeneration, and more.
Full story
-
Feb 28, 2022, 11:48 AM
by
User Not Found
Bio-IT World | AI and ML in immunological therapeutic development, virtual drug screening, microscope-based rapid pathogen diagnostics, improved genetic variant interpretation, and more.
Full story
-
Feb 25, 2022, 01:00 AM
by
User Not Found
Bio-IT World | The clock is ticking on implementing the EMA's IDMP standard. With the release of EU IG v2.1, the industry is in the final stages of preparations for optional submission. While regulatory teams have made progress applying guidance to uniquely identify products and standardize information, more work remains to establish a proper data foundation that supports submissions under the new requirements.
Full story